Back

The eligibility of patients with an inherited cardiac disease for therapy with a subcutaneous implantable cardioverter-defibrillator.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Device treatment of arrhythmias Device Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Virginnio Proost

Amsterdam University Medical Centre (AUMC), Amsterdam (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Subcutaneous Implantable Defibrillator programming: an analysis of Italian clinical practice and its evolution.
Doctor S. Valsecchi (Milan, IT)
Abstract Slides
Presentation thumbnail
3 Tesla magnetic resonance imaging in patients with cardiac electronic implantable devices: a single center experience
Doctor J. Nikorowitsch (Hamburg, DE)
Abstract Slides
Presentation thumbnail
Ventricular tachycardia ablation before an implantable cardioverter defibrillator in secondary prevention: is always the best option?
Doctor A. Martinho (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Single-Chamber versus Dual-Chamber Pacing in very elderly patients with Sinus Node Disease and AV Block: A real-world study
Doctor A. Bedir (Dartford, GB)
Abstract Slides
Presentation thumbnail
Benefit of right inferior pacing on conduction across Bachmanns Bundle
Mr M. Van Schie (Rotterdam, NL)
Abstract Slides

Access the full session

Session thumbnail
Device treatment of arrhythmias

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources